Haig P. Bozigian, Chief Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 5,540 shares at $103.06 ($567K) on 2020-02-05, disclosed to the SEC on 2020-02-07.
Seasonal sale ($567k) by Chief Development Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.00 | 1,342 | $138K | 24.4% |
| 2 | $103.06 | 704 | $73K | 12.8% |
| 3 | $103.06 | 704 | $73K | 12.8% |
| 4 | $101.56 | 1,395 | $142K | 25.0% |
| 5 | $101.56 | 1,395 | $142K | 25.0% |
| Total | $102.29 avg | 5,540 |
| $567K |
| 100% |
| Filing → |
| NBIX | SELL | 2020-08-07 | $537K | — | Filing → |
| NBIX | SELL | 2020-05-14 | $14.2M | — | Filing → |
| NBIX | SELL | 2020-04-28 | $385K | — | Filing → |